ConductScience.org, home

Paper8097082

Zalcitabine compared with zidovudine in patients with advanced HIV-1 infection who received previous zidovudine therapy.

Fischl MA and 11 others. Ann Intern Med, 1993. Cited by 80 papers, by iCite.

Cite this record

ConductScience Library. Zalcitabine compared with zidovudine in patients with advanced HIV-1 infection who received previous zidovudine therapy. Papers, record 8097082. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8097082

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Zalcitabine compared with zidovudine in patients with advanced HIV-1 infection who received previous zidovudine therapy.
PubMed
Journal
Ann Intern Med
PubMed
Year
1993
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
80
iCite
Relative citation ratio, by iCite
2.64
iCite
Revised in PubMed
2019-06-19
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fischl MAM A
2Olson RMR M
3Follansbee SES E
4Lalezari JPJ P
5Henry DHD H
6Frame PTP T
7Remick SCS C
8Salgo MPM P
9Lin AHA H
10Nauss-Karol CC
11Lieberman JJ
12Soo WW

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HIV InfectionsMajor topic
HIV-1Major topic
ZalcitabineMajor topic
ZidovudineMajor topic
Adult
Body Weight
CD4-Positive T-Lymphocytes
Female
HIV Core Protein p24
Humans
Leukocyte Count
Male
Regression Analysis
Severity of Illness Index
Survival Rate

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00000678
Dideoxycytidine ( Ro 24-2027 ) A Randomized, Open-Label, Comparative Study of Dideoxycytidine ( ddC ) Versus Zidovudine ( AZT ) in Patients With AIDS or Advanced ARC Who Have Received Long-Term AZT Therapy.
Background

Source ClinicalTrials.gov

Download CSV of trials

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in8470857The hazards of misguided compassion.https://conductscience.org/library/papers/8470857

Source PubMed

Download CSV of comments and corrections

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 80 citations.

PMIDTitleJournalYearIn PapersSource
21343462Combinatorial approaches to the prevention and treatment of HIV-1 infection.Antimicrob Agents Chemother2011https://conductscience.org/library/papers/21343462PubMed
18474576Nonclinical safety profile of telbivudine, a novel potent antiviral agent for treatment of hepatitis B.Antimicrob Agents Chemother2008https://conductscience.org/library/papers/18474576PubMed
10163413Combination antiretroviral therapy in HIV infection. An economic perspective.Pharmacoeconomics1996https://conductscience.org/library/papers/10163413PubMed
9527795Zalcitabine population pharmacokinetics: application of radioimmunoassay.Antimicrob Agents Chemother1998https://conductscience.org/library/papers/9527795PubMed
9517872Frequency and determinants of use of antiretroviral and prophylactic therapies against Pneumocystis carinii Pneumonia (PCP) before AIDS diagnosis in Italy.Eur J Epidemiol1998https://conductscience.org/library/papers/9517872PubMed
9179531Zalcitabine. An update of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of HIV infection.Drugs1997https://conductscience.org/library/papers/9179531PubMed
8901366Health-related quality of life of HIV-infected women: evidence for the reliability, validity and responsiveness of the Medical Outcomes Study Short-Form 20.Qual Life Res1996https://conductscience.org/library/papers/8901366PubMed
8879972Treatment of HIV infection. Tolerability of commonly used antiretroviral agents.Drug Saf1996https://conductscience.org/library/papers/8879972PubMed
7795555Concise overview of the clinical pharmacokinetics of dideoxynucleoside antiretroviral agents.Pharm World Sci1995https://conductscience.org/library/papers/7795555PubMed
7705214The effects of long term zidovudine therapy and Pneumocystis carinii prophylaxis on HIV disease. A review of the literature.Drugs1995https://conductscience.org/library/papers/7705214PubMed
7693435Zidovudine. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.Drugs1993https://conductscience.org/library/papers/7693435PubMed
7614775Zalcitabine. Clinical pharmacokinetics and efficacy.Clin Pharmacokinet1995https://conductscience.org/library/papers/7614775PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8097082

GET https://conductscience.org/api/papers/v1/8097082/authors